The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options

The mechanisms leading to disability and the long-term efficacy and safety of disease modifying drugs (DMDs) in multiple sclerosis (MS) are unclear. We aimed at building a prospective cohort of MS patients with standardized collection of demographic, clinical, MRI data and body fluids that can be us...

Descripción completa

Detalles Bibliográficos
Autores principales: Disanto, Giulio, Benkert, Pascal, Lorscheider, Johannes, Mueller, Stefanie, Vehoff, Jochen, Zecca, Chiara, Ramseier, Simon, Achtnichts, Lutz, Findling, Oliver, Nedeltchev, Krassen, Radue, Ernst-Wilhelm, Sprenger, Till, Stippich, Christoph, Derfuss, Tobias, Louvion, Jean-François, Kamm, Christian P., Mattle, Heinrich P., Lotter, Christoph, Du Pasquier, Renaud, Schluep, Myriam, Pot, Caroline, Lalive, Patrice H., Yaldizli, Özgür, Gobbi, Claudio, Kappos, Ludwig, Kuhle, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816556/
https://www.ncbi.nlm.nih.gov/pubmed/27032105
http://dx.doi.org/10.1371/journal.pone.0152347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816556/
https://www.ncbi.nlm.nih.gov/pubmed/27032105
http://dx.doi.org/10.1371/journal.pone.0152347

Ejemplares similares